Considerations on the Calculation of the Human Equivalent Dose from Toxicology Studies for Biologic Anticancer Agents Mohamed ElmeliegyChandrasekhar UdataDonghua Yin Editorial Open access 02 March 2021 Pages: 563 - 567
Pharmacokinetic, Pharmacodynamic, and Drug-Interaction Profile of Remdesivir, a SARS-CoV-2 Replication Inhibitor Rita HumeniukAnita MathiasPolina German Review Article Open access 30 March 2021 Pages: 569 - 583
Drug-Metabolizing Cytochrome P450 Enzymes Have Multifarious Influences on Treatment Outcomes Yurong SongChenxi LiYuanyan Liu Review Article 16 March 2021 Pages: 585 - 601
Supra-therapeutic Linezolid Trough Concentrations in Elderly Patients: A Call for Action? Dario CattaneoMarta FusiEmilio Clementi Original Research Article 12 November 2020 Pages: 603 - 609
Clinical Pharmacokinetics and Bayesian Estimators for the Individual Dose Adjustment of a Generic Formulation of Tacrolimus in Adult Kidney Transplant Recipients Pierre MarquetAlexandre DestèreJean Debord Original Research Article 24 November 2020 Pages: 611 - 622
Dose Adjustment of Quetiapine and Aripiprazole for Pregnant Women Using Physiologically Based Pharmacokinetic Modeling and Simulation Liang ZhengShiwei TangLing Wang Original Research Article 30 November 2020 Pages: 623 - 635
Application of Physiologically Based Pharmacokinetic Modeling to Predict the Effect of Renal Impairment on the Pharmacokinetics of Olanzapine and Samidorphan Given in Combination Lei SunLisa von MoltkeKaren Rowland Yeo Original Research Article Open access 14 December 2020 Pages: 637 - 647
Rethinking the Application of Pemetrexed for Patients with Renal Impairment: A Pharmacokinetic Analysis Nikki de RouwRene J. BoosmanRob ter Heine Original Research Article Open access 09 January 2021 Pages: 649 - 654
Population Pharmacokinetics of Levetiracetam in Patients with Traumatic Brain Injury and Subarachnoid Hemorrhage Exhibiting Augmented Renal Clearance Fekade Bruck SimeJason A. RobertsMenino Osbert Cotta Original Research Article 11 January 2021 Pages: 655 - 664
Limited Systemic Exposure with Topical Glycopyrronium Tosylate in Primary Axillary Hyperhidrosis David M. PariserEdward L. LainDiane R. Mould Original Research Article Open access 12 January 2021 Pages: 665 - 676
Comment on: "Preterm Physiologically Based Pharmacokinetic Model, Part I and Part II” Swantje VöllerRobert B. FlintCatherijne A. J. Knibbe Letter to the Editor 13 March 2021 Pages: 677 - 679
Authors’ Reply to Völler et al: “Comment on: Preterm Physiologically Based Pharmacokinetic Model, Part I and Part II” Khaled AbduljalilXian PanTrevor N. Johnson Letter to the Editor 13 March 2021 Pages: 681 - 683
